Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Astiazaran-Symonds

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Gastroenterology|July 13, 2021
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancerEsteban Astiazaran-Symonds, Alisa M Goldstein
Cancer Informatics|January 19, 2023
Visualization and Quantification of the Association Between Breast Cancer and Cholesterol in the All of Us Research ProgramJianglin Feng, Esteban Astiazaran Symonds, Jason H Karnes
American Journal of Medical Genetics. Part A|August 18, 2020
Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2Changrui Xiao, Esteban Astiazaran-Symonds, Shrabani Basu, et al.
British Journal of Cancer|March 25, 2023
Cancer in Costello syndrome: a systematic review and meta-analysisEsteban Astiazaran-Symonds, Gina M Ney, Cecilia Higgs, et al.
Cancers|July 9, 2022
A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility GenesEsteban Astiazaran-Symonds, Jung Kim, Jeremy S Haley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 31, 2026
Consideration of inherited cancer risk on a continuum: An international and multidisciplinary perspective: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Joseph Christopher, Esteban Astiazaran-Symonds, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 25, 2023
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Helen Hanson, Esteban Astiazaran-Symonds, Laura M Amendola, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 29, 2023
Response to SternHelen Hanson, Esteban Astiazaran-Symonds, Laura M Amendola, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 5, 2024
Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Katherine R Schon, Esteban Astiazaran-Symonds, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genesJung Kim, Gina Ney, Megan N Frone, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Gastroenterology|July 13, 2021
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancerEsteban Astiazaran-Symonds, Alisa M Goldstein
Cancer Informatics|January 19, 2023
Visualization and Quantification of the Association Between Breast Cancer and Cholesterol in the All of Us Research ProgramJianglin Feng, Esteban Astiazaran Symonds, Jason H Karnes
American Journal of Medical Genetics. Part A|August 18, 2020
Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2Changrui Xiao, Esteban Astiazaran-Symonds, Shrabani Basu, et al.
British Journal of Cancer|March 25, 2023
Cancer in Costello syndrome: a systematic review and meta-analysisEsteban Astiazaran-Symonds, Gina M Ney, Cecilia Higgs, et al.
Cancers|July 9, 2022
A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility GenesEsteban Astiazaran-Symonds, Jung Kim, Jeremy S Haley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 31, 2026
Consideration of inherited cancer risk on a continuum: An international and multidisciplinary perspective: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Joseph Christopher, Esteban Astiazaran-Symonds, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 25, 2023
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Helen Hanson, Esteban Astiazaran-Symonds, Laura M Amendola, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 29, 2023
Response to SternHelen Hanson, Esteban Astiazaran-Symonds, Laura M Amendola, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 5, 2024
Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Katherine R Schon, Esteban Astiazaran-Symonds, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genesJung Kim, Gina Ney, Megan N Frone, et al.
Pageof 2